Monopar and NorthStar Announce Expanded Radiopharma Program, Positive Preclinical Results, and Visibility Toward Human Trials
February 27, 2023 07:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, Ill.) and NorthStar Medical Radioisotopes, LLC (Beloit, Wis.), today announced...
Monopar and NorthStar Announce Filing of Composition of Matter Patent Protecting MNPR-101 Radiotherapeutic
May 26, 2021 08:00 ET
|
Monopar Therapeutics Inc.; NorthStar Medical Radioisotopes, LLC
WILMETTE, Ill. and BELOIT, Wis., May 26, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery
May 24, 2021 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional...
Monopar and NorthStar Announce Selection of uPRIT Candidate for Potential Treatment of Severe COVID-19
December 10, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, which are jointly developing a urokinase...
Monopar and NorthStar Collaborating with Texas Lung Injury Institute for Testing of Novel Potential Therapeutic for Severe COVID-19
September 09, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., BELOIT, Wis. and TYLER, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, which are jointly developing...
Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19
August 19, 2020 08:30 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill. and BELOIT, Wis. and MORGAN HILL, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Wilmette, IL) and NorthStar Medical Radioisotopes, LLC (Beloit,...
Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19
June 16, 2020 08:25 ET
|
Monopar Therapeutics Inc.
CHICAGO and BELOIT, Wis., June 16, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (Chicago, IL) and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced today a 50/50...
Cetera Investments Services Alert! Shepherd, Smith, Edwards & Kantas LLP Files Claim Against Cetera and Advisor Howard Hsieh
July 16, 2019 11:32 ET
|
Shepherd Smith Edwards & Kantas LLP
LOS ANGELES, July 16, 2019 (GLOBE NEWSWIRE) -- Lawyers with Shepherd, Smith, Edwards, & Kantas recently filed a claim on behalf of clients alleging that Cetera Investments Services, LLC...
Cross Keys Capital Completes Sale of Square Waveform Anesthesiology to NorthStar Anesthesia
November 16, 2016 08:00 ET
|
Cross Keys Capital, LLC.
Fort Lauderdale, Fla., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to healthcare companies, is...
BEW Global Assists NorthStar Financial Services Group, LLC With ISO 27001 Certification
November 21, 2013 13:03 ET
|
BEW Global, Inc.
GREENWOOD VILLAGE, CO--(Marketwired - Nov 21, 2013) - BEW Global, an industry leader in data and critical asset protection programs, announced that their client, NorthStar Financial Services Group,...